Captrust Financial Advisors Heron Therapeutics, Inc. Transaction History

Captrust Financial Advisors

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.54 - $1.82 $18,030 - $60,769	33,390 Added 188.52%	51,102 $86,000
Q3 2023 Nov 14, 2023	SELL	$0.97 - $1.8 $6,012 - $11,156	-6,198 Reduced 25.92%	17,712 $18,000
Q2 2023 Aug 14, 2023	SELL	$1.11 - $2.88 $1,822 - $4,728	-1,642 Reduced 6.43%	23,910 $27,000
Q1 2023 May 15, 2023	BUY	$1.51 - $3.25 $38,583 - $83,044	25,552 New	25,552 $38,000
Q3 2022 Nov 16, 2022	BUY	$2.66 - $5.37 $54,878 - $110,788	20,631 Added 3638.62%	21,198 $89,000
Q2 2022 Aug 23, 2022	SELL	$2.3 - $6.29 $39,610 - $108,326	-17,222 Reduced 96.81%	567 $2,000
Q2 2022 Aug 16, 2022	BUY	$2.3 - $6.29 $38,419 - $105,068	16,704 Added 1539.54%	17,789 $50,000
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $2,611 - $5,606	564 Added 108.25%	1,085 $6,000
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $3,089 - $4,662	-370 Reduced 41.53%	521 $5,000
Q3 2021 Nov 16, 2021	SELL	$10.13 - $15.0 $1,043 - $1,545	-103 Reduced 10.36%	891 $10,000
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $6,688 - $9,313	504 Added 102.86%	994 $15,000
Q1 2021 May 17, 2021	BUY	$14.49 - $20.72 $5,651 - $8,080	390 Added 390.0%	490 $8,000
Q3 2020 Nov 17, 2020	SELL	$13.67 - $17.77 $1,367 - $1,777	-100 Reduced 50.0%	100 $2,000
Q2 2020 Aug 14, 2020	BUY	$10.89 - $21.47 $2,178 - $4,294	200 New	200 $3,000
Q4 2019 Feb 14, 2020	SELL	$17.42 - $26.61 $24,318 - $37,147	-1,396 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$16.36 - $21.39 $19,566 - $25,582	1,196 Added 598.0%	1,396 $26,000
Q3 2018 Nov 15, 2018	BUY	$30.0 - $40.85 $6,000 - $8,170	200 New	200 $6,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.